Phase 2 Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have recently given birth
- People who were diagnosed with preeclampsia (a pregnancy complication involving high blood pressure) during their most recent pregnancy
- People who are within the first or second week after giving birth
- People who are able to give their own informed consent to participate
Who may not be able to join:
- People who had high blood pressure before their pregnancy (not caused by pregnancy)
- People with a history of serious heart or blood vessel disease
- People who currently have an active infection affecting the whole body
- People who have a history of endothelial injury (damage to the inner lining of blood vessels) (confirm with trial site)
- People who currently smoke, vape, or have an active addiction to alcohol or drugs
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Akhmad Y Pramatirta, M.D., Ph.D, Dr. Hasan Sadikin Central General Hospital
Phone: +62 85721368609
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Endothelial Function Biomarker (miR-126-3p)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.